Insider Trading & Ownership - Cross John Harry III

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cross John Harry III

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-03-07
Option Award
2025-03-11
4:14 pm
N/A
2035-03-06
Senti Biosciences Inc. SNTI Cross John Harry III
Chief Financial Officer
174,200 $0 174,200
(Direct)
View
2023-12-11
Option Award
2024-12-05
9:55 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc. SONN Cross John Harry III
Chief Financial Officer
1,452 $0 1,588
(Direct)
View
2023-02-06
Tax Withholding
2023-02-17
4:45 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc. SONN Cross John Harry III
Chief Financial Officer
1,960 $1.06 23,927
(Direct)
View
2022-12-14
Option Award
2022-12-22
4:31 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc. SONN Cross John Harry III
Chief Financial Officer
15,519 $0 160,684
(Direct)
View
2021-12-15
Option Award
2022-04-08
4:30 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc. SONN Cross John Harry III
Chief Financial Officer
66,951 $0 145,165
(Direct)
View
2020-07-02
Option Award
2020-07-02
6:17 pm
N/A
N/A
Sonnet BioTherapeutics Holdings Inc. SONN Cross John Harry III
Chief Financial Officer
78,214 $0 78,214
(Direct)
View